NextSDS Logo
Chemical Substance

2R)‐2‐[(2R,5S,6R)‐6‐[(2S,3S,4S,6R)‐6‐[(2S,5S,7R,9S,10S,12R,15R)‐2‐[(2R,5R,6S)‐5‐Ethyl‐5‐hydroxy‐6‐methyloxan‐2‐yl]‐15‐hydroxy‐2,10,12‐trimethyl‐1,6,8‐trioxadispiro[4.1.57.35]pentadec‐13‐en‐9‐yl]‐3‐hydroxy‐4‐methyl‐5‐oxooctan‐2‐yl]‐5‐methyloxan‐2‐yl]butanoic acid sodium hydride

CAS Number 55721-31-8
EC Number 611-309-0
Molecular Formula C42H71NaO12
SDS management

Is this substance in your SDS library?

NextSDS finds every safety data sheet that contains it, flags new hazard classifications and keeps your whole SDS library current for every site.

Identifiers

Cas Number 55721-31-8 Primary
Ec Number 611-309-0
Chemical Name Salinomycin
Chemical Name Salinomycin sodium salt
Chemical Name 2R)‐2‐[(2R,5S,6R)‐6‐[(2S,3S,4S,6R)‐6‐[(2S,5S,7R,9S,10S,12R,15R)‐2‐[(2R,5R,6S)‐5‐Ethyl‐5‐hydroxy‐6‐methyloxan‐2‐yl]‐15‐hydroxy‐2,10,12‐trimethyl‐1,6,8‐trioxadispiro[4.1.57.35]pentadec‐13‐en‐9‐yl]‐3‐hydroxy‐4‐methyl‐5‐oxooctan‐2‐yl]‐5‐methyloxan‐2‐yl]butanoic acid sodium hydride

GHS Hazard Pictograms

GHS06 Hazard Pictogram GHS06

Hazard Classifications

Acute Tox. 3
Acute toxicity (oral + dermal + inhalation)
Danger
Hazard Code H301 + H311 + H331
Category Acute Tox. 3
Source: Notified C&L

Related Substances

(2R)-2-{(2R,3S,5S,6R)-6-[(1S,2S,3S,5R)-5-{(2S,5S,7R,9S,10S,12R,15R)-2-[(2R,5R,6S)-5-ethyl-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]-15-hydroxy-2,10,12-trimethyl-1,6,8-trioxadispiro[4.1.5.3]pentadec-13-en-9-yl}-2-hydroxy-1,3-dimethyl-4-oxoheptyl]-3,5-dimethyltetrahydro-2H-pyran-2-yl}butanoic acid
55134-13-9
N-[(2S,3R,4S,6R)-2-[[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-6-yl]oxy]-3-hydroxy-6-methyloxan-4-yl]-N-methylpropanamide
147702-49-6
(2R,4R,5R,6R)-4-[(2R,4R,5R,6R)-2-carboxy-6-[(1R)-1,2-dihydroxyethyl]-4 ,5-dihydroxy-oxan-2-yl]oxy-6-[(1R)-1,2-dihydroxyethyl]-5-hydroxy-2-[[( 2R,3S,4R,5R,6R)-6-[[(2R,3S,4R,5R,6R)-3-hydroxy-5-[[(3R)-3-hydroxytetra decanoyl]amino]-4-[(3R)-3-hydroxytetradecanoyl]oxy-6-phosphonooxy-oxan -2-yl]methoxy]-5-[[(3R)-3-hydroxytetradecanoyl]amino]-4-[(3R)-3-hydrox ytetradecanoyl]oxy-3-phosphonooxy-oxan-2-yl]methoxy]oxane-2-carboxylic acid
143600-83-3
(2R,3R,4S,5R,6R)-2-(hydroxymethyl)-6-[[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-[(6R)-6-[(3S,8S,9R,10S,11R,13R,14S,17R)-11-hydroxy-4,4,9,13,14-pentamethyl-3-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3,7,8,10,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-hept-2-enoxy]oxan-2-yl]methoxy]oxane-3,4,5-triol
109985-95-7
6-[[11-carboxy-9-[4,5-dihydroxy-3-[2,4,5-trihydroxy-6-(hydroxymethyl)o xan-3-yl]oxy-oxan-2-yl]oxy-4-(hydroxymethyl)-4,6a,6b,8a,11,14b-hexamet hyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]- 5-[4,5-dihydroxy-6-(hydroxymethyl)-3-(3,4,5-trihydroxy-6-methyl-oxan-2 -yl)oxy-oxan-2-yl]oxy-3,4-dihydroxy-oxane-2-carboxylic acid
147666-63-5

Disclaimer

The substance data provided is sourced from various third-party databases and regulatory sources. While we strive to maintain accuracy, we cannot guarantee the completeness, accuracy, or timeliness of this information. Users are responsible for verifying all data before use in compliance, safety, or regulatory contexts. NextSDS is not liable for any decisions made based on this data.